BlackRock Fund Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $12.6M | Buy |
119,960
+9,841
| +9% | +$1.04M | ﹤0.01% | 2449 |
|
|
2016
Q3 | $12.2M | Buy |
110,119
+8,108
| +8% | +$896K | ﹤0.01% | 2348 |
|
|
2016
Q2 | $14.9M | Buy |
102,011
+46,360
| +83% | +$6.75M | ﹤0.01% | 2192 |
|
|
2016
Q1 | $7.97M | Buy |
55,651
+4,879
| +10% | +$699K | ﹤0.01% | 2484 |
|
|
2015
Q4 | $7.85M | Buy |
+50,772
| New | +$7.85M | ﹤0.01% | 2587 |
|
|
2014
Q4 | – | Sell |
-48
| Closed | -$7K | – | 3885 |
|
|
2014
Q3 | $7K | Sell |
48
-3
| -6% | -$437 | ﹤0.01% | 3805 |
|
|
2014
Q2 | $7K | Hold |
51
| – | – | ﹤0.01% | 3761 |
|
|
2014
Q1 | $6K | Hold |
51
| – | – | ﹤0.01% | 3751 |
|
|
2013
Q4 | $5K | Sell |
51
-3,952
| -99% | -$387K | ﹤0.01% | 3763 |
|
|
2013
Q3 | $304K | Buy |
4,003
+477
| +14% | +$36.2K | ﹤0.01% | 3270 |
|
|
2013
Q2 | $197K | Buy |
+3,526
| New | +$197K | ﹤0.01% | 3320 |
|